CDE Issues Guidelines for Bispecific Antibody Antitumor Drug Development
The Center for Drug Evaluation (CDE) has released the “Technical Guidelines for Clinical Research and...
Policy / Regulatory
China Updates Hypertension Guidelines, Lowers Diagnostic Threshold
The National Center for Cardiovascular Diseases, the Chinese Medical Doctor Association (CMDA), and other organizations...
China Releases 14th Five-Year Plan for National Health Informatization
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and the National Bureau...
CDE Seeks Public Feedback on New Drug Benefit-Risk Assessment Guidelines
The Center for Drug Evaluation (CDE) has released the “New Drug Benefit-Risk Assessment Technical Guidelines,”...
CDE Releases Draft Guidelines on New Drug Benefit-Risk Assessment
The Center for Drug Evaluation (CDE) has released the “New Drug Benefit-Risk Assessment Technical Guidelines,”...
CDE Releases Guidelines on Pediatric Anti-tumor Drug Development
The Center for Drug Evaluation (CDE) has released a Technical Guidelines document focused on “Clinical...
Hainan Free Trade Port to Simplify Drug Import Procedures
The “Provisions on Facilitation of Drug Import in Hainan Free Trade Port,” released in September...
NMPA Proposes ‘Drug Online Sales Blacklist’ for Public Feedback
The National Medical Products Administration (NMPA) has released a draft proposal for a “Drug Online...
Shanghai SMPA Suspends HEC’s Linagliptin Procurement Over Patent Infringement
The Shanghai Sunshine Medical Procurement All-in-One (SMPA) platform has revealed that it has suspended the...
NMPA Suspends GSK’s Avodart Amid Inspection Findings
The National Medical Products Administration (NMPA) has decided to suspend the import, sales, and use...
China’s National Plan to Combat Microbial Drug Resistance Released
The National Health Commission (NHC), Ministry of Education, Ministry of Science and Technology, and 10...
Ortho-K Lenses Included in Hebei’s Volume-Based Procurement List
The drug and medical device procurement center of Hebei Province released a notification regarding the...
Shanghai Launches Inhaled COVID-19 Vaccine Booster Program
On October 25, Shanghai began accepting patient reservations for the inhalable recombinant COVID-19 vaccine (adenovirus...
China’s NMPA Issues New Drug Recall Management Measures
The National Medical Products Administration (NMPA) has released the “Drug Recall Management Measures,” which took...
Fujian Procurement Center Announces VBP for Cardiac and Laparoscopic Medical Consumables
The Fujian drug and device joint procurement center has released two separate notifications regarding the...
NMPA Releases 61st Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 61st batch of reference drugs for...
Shaanxi Releases Notice for Inter-Provincial Orthodontic Brackets VBP
The Shaanxi Public Resources Trading Center has released the “Inter-provincial Alliance (regions, Corps) Orthodontic Brackets...
NHSA Responds to Proposal on Dental Implants’ Inclusion in NRDL
The National Healthcare Security Administration (NHSA) has responded to the No. 6184 suggestion from the...
NHSA Completes Expert Review for NRDL Price Negotiation Process
The National Healthcare Security Administration (NHSA) has released a notification indicating that the expert review...
CDE Releases Draft Guidelines for Extrapolating Adult Drug Data to Pediatric Use
The Center for Drug Evaluation (CDE) has released the “Guidelines on Quantitative Methodology for Extrapolating...